Published in Am J Nephrol on June 20, 2015
The emerging threat of superwarfarins: history, detection, mechanisms, and countermeasures. Ann N Y Acad Sci (2016) 0.83
The Severity of Intracranial Hemorrhages Measured by Free Hemoglobin in the Brain Depends on the Anticoagulant Class: Experimental Data. Stroke Res Treat (2017) 0.75
2013 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 31st Annual Report. Clin Toxicol (Phila) (2014) 2.59
Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis (2009) 2.21
Traumatic haemogloinuria caused by karate exercises. Lancet (1967) 1.75
Superwarfarin poisoning. Arch Intern Med (1998) 1.35
The mechanism of mitochondrial swelling. V. Permeability of mitochondria to alkali metal salts of strong acid anions. J Bioenerg (1970) 1.28
Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation. J Am Soc Nephrol (2011) 1.17
Pharmacokinetics of eight anticoagulant rodenticides in mice after single oral administration. J Vet Pharmacol Ther (2008) 1.14
Long-acting anticoagulant overdose: brodifacoum kinetics and optimal vitamin K dosing. Ann Emerg Med (2000) 1.12
5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol (2012) 1.10
N-acetylcysteine ameliorates acute kidney injury but not glomerular hemorrhage in an animal model of warfarin-related nephropathy. Am J Physiol Renal Physiol (2013) 0.98
Superwarfarin intoxication: hematuria is a major clinical manifestation. Int J Hematol (2009) 0.94
Brodifacoum poisoning with toxicokinetic data. Clin Toxicol (Phila) (2007) 0.89
Mitochondrial toxicity of 2-bromohydroquinone in rabbit renal proximal tubules. Toxicol Appl Pharmacol (1987) 0.86
Case management and plasma half-life in a case of brodifacoum poisoning. Arch Intern Med (1993) 0.85
Outcomes of patients with rodenticide poisoning at a far east poison center. Springerplus (2013) 0.85
How I treat poisoning with vitamin K antagonists. Blood (2014) 0.81
Effects of subacute oral warfarin administration on peripheral blood granulocytes in rats. Food Chem Toxicol (2012) 0.81
Early mitochondrial disfunction in bromobenzene treated mice: a possible factor of liver injury. Biochem Pharmacol (1990) 0.78
Hematocrit and metabolic changes caused by varied resuscitation strategies in a canine model of hemorrhagic shock. Am J Emerg Med (2002) 0.78
Vitamin K1 (phylloquinone) induces vascular endothelial dysfunction: role of oxidative stress. Toxicol Appl Pharmacol (2005) 0.78
Scaling of physiological responses: a new approach for hemorrhagic shock. Am J Physiol (1986) 0.77
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science (2005) 17.00
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA (2002) 12.29
The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol (2004) 7.38
The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int (2004) 4.77
Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int (2011) 4.51
Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity. Reg Anesth Pain Med (2003) 3.87
Lipid emulsion is superior to vasopressin in a rodent model of resuscitation from toxin-induced cardiac arrest. Crit Care Med (2009) 3.56
Rapid cardiotonic effects of lipid emulsion infusion*. Crit Care Med (2013) 2.76
Lipid infusion accelerates removal of bupivacaine and recovery from bupivacaine toxicity in the isolated rat heart. Reg Anesth Pain Med (2006) 2.74
Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis (2003) 2.68
Management of glomerular proteinuria: a commentary. J Am Soc Nephrol (2003) 2.59
Typing of amyloidosis in renal biopsies: diagnostic pitfalls. Arch Pathol Lab Med (2007) 2.50
Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2003) 2.47
Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol (2009) 2.45
HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci U S A (2002) 2.31
Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis (2009) 2.21
Lipid infusion resuscitation for local anesthetic toxicity: proof of clinical efficacy. Anesthesiology (2006) 2.21
Epinephrine impairs lipid resuscitation from bupivacaine overdose: a threshold effect. Anesthesiology (2009) 2.11
Myocardial bridging of coronary arteries: A risk factor for myocardial fibrosis? Int J Cardiol (2007) 2.01
Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine (2005) 2.00
Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am J Physiol Heart Circ Physiol (2005) 1.90
Cell elongation is key to in silico replication of in vitro vasculogenesis and subsequent remodeling. Dev Biol (2005) 1.90
Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis. Ann Neurol (2002) 1.86
Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension (2002) 1.83
A composite urine biomarker reflects interstitial inflammation in lupus nephritis kidney biopsies. Kidney Int (2011) 1.77
The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. Arch Intern Med (2005) 1.76
Activation of the Nrf2/antioxidant response pathway increases IL-8 expression. Eur J Immunol (2005) 1.74
Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology (Oxford) (2011) 1.70
Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. Am J Kidney Dis (2006) 1.68
In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation. J Pharm Sci (2004) 1.63
Proteinuria in a patient receiving anti-VEGF therapy for metastatic renal cell carcinoma. Nat Clin Pract Nephrol (2007) 1.63
Warfarin therapy that results in an International Normalization Ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease. Nephron Clin Pract (2010) 1.62
Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. J Neurochem (2007) 1.61
Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria. J Am Soc Nephrol (2009) 1.57
Tolerating increases in the serum creatinine following aggressive treatment of chronic kidney disease, hypertension and proteinuria: pre-renal success. Am J Nephrol (2012) 1.57
Pulmonary adverse events of anti-tumor necrosis factor-alpha antibody therapy. Am J Med (2006) 1.57
Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology. Am J Pathol (2006) 1.57
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study. Arthritis Res Ther (2009) 1.54
Inflammation and obstructive sleep apnea syndrome: how many ways do I look at thee? Chest (2004) 1.54
Resuscitation with lipid emulsion: dose-dependent recovery from cardiac pharmacotoxicity requires a cardiotonic effect. Anesthesiology (2014) 1.53
Biomarkers of lupus nephritis determined by serial urine proteomics. Kidney Int (2008) 1.51
Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain (2011) 1.50
Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress. Am J Physiol Heart Circ Physiol (2005) 1.50
Noradrenergic depletion potentiates beta -amyloid-induced cortical inflammation: implications for Alzheimer's disease. J Neurosci (2002) 1.46
Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus. Kidney Int (2005) 1.40
Intravenous lipid emulsion in clinical toxicology. Scand J Trauma Resusc Emerg Med (2010) 1.39
Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis. Arthritis Rheum (2012) 1.32
An unusual cause of gross hematuria and transient ARF in an SLE patient with warfarin coagulopathy. Am J Kidney Dis (2004) 1.31
Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis. J Neuroimmunol (2005) 1.29
Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen. J Am Soc Nephrol (2004) 1.29
Sterically stabilized phospholipid mixed micelles: in vitro evaluation as a novel carrier for water-insoluble drugs. Pharm Res (2003) 1.28
Resuscitation with lipid versus epinephrine in a rat model of bupivacaine overdose. Anesthesiology (2008) 1.28
Staphylococcus infection-associated glomerulonephritis mimicking IgA nephropathy. Clin J Am Soc Nephrol (2006) 1.26
A dinucleotide deletion in CD24 confers protection against autoimmune diseases. PLoS Genet (2007) 1.25
A prospective study of protein excretion using short-interval timed urine collections in patients with lupus nephritis. Kidney Int (2009) 1.24
Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline. J Neurosci (2009) 1.22
Proliferative glomerulonephritis with monoclonal IgG deposits recurs or may develop de novo in kidney allografts. Am J Kidney Dis (2011) 1.20
A novel fluorescent probe that is brain permeable and selectively binds to myelin. J Histochem Cytochem (2006) 1.19
The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1. ASN Neuro (2011) 1.19
Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes. J Biol Chem (2002) 1.18
Proposed pathogenesis of idiopathic loin pain-hematuria syndrome. Am J Kidney Dis (2006) 1.18
Intravital videomicroscopy of peritubular capillaries in renal ischemia. Am J Physiol Renal Physiol (2002) 1.17
Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation. J Am Soc Nephrol (2011) 1.17
Noradrenergic regulation of inflammatory gene expression in brain. Neurochem Int (2002) 1.17
Markers of inflammation in exhaled breath condensate of young healthy smokers. Chest (2004) 1.16
The intricate role of complement component C4 in human systemic lupus erythematosus. Curr Dir Autoimmun (2004) 1.15
Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int (2002) 1.15
Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment. Mol Pharmacol (2006) 1.14
Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus. Proc Natl Acad Sci U S A (2007) 1.13
P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis. J Neuroinflammation (2008) 1.12
A within-patient analysis for time-varying risk factors of CKD progression. J Am Soc Nephrol (2013) 1.11
Glycated collagen I induces premature senescence-like phenotypic changes in endothelial cells. Circ Res (2002) 1.11
Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease. Neurobiol Aging (2006) 1.11
IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression. Mod Pathol (2013) 1.10
The clinical course of experimental autoimmune encephalomyelitis is associated with a profound and sustained transcriptional activation of the genes encoding toll-like receptor 2 and CD14 in the mouse CNS. Brain Pathol (2002) 1.10
Identification of complement 5a-like receptor (C5L2) from astrocytes: characterization of anti-inflammatory properties. J Neurochem (2005) 1.10